TABLE 4.

One-Way Sensitivity Analysis of Cost Per Case Prevented Across a Range of Incidence of Kernicterus*

StrategyAnnual Kernicterus IncidenceNo. of Cases Prevented Per YearAnnual Cost for Entire Cohort, $Cost Per Case Prevented, $
Universal follow up10 00019643 540 671222 146
50 00039184 660 6714 710 731
100 00020202 300 67110 321 463
250 0008212 884 67127 153 657
500 0004216 412 67155 207 314
Predischarge serum bilirubin10 000196−46 179 465−235 610
50 0003994 940 5352 421 952
100 00020112 580 5355 743 905
250 0008123 164 53515 709 762
500 0004126 692 53532 319 524
Predischarge transcutaneous bilirubin10 00019621 390 494109 135
50 00039162 510 4944 145 676
100 00020180 150 4949 191 352
250 0008190 734 49424 328 379
500 0004194 262 49449 556 759
  • * An RRR of 0.7 is assumed for each strategy.

  • Number of healthy term live births out of which 1 case of kernicterus occurs.